Zealand Pharma A/S

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 319.75% vs -46.36% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -17.51% vs -46.68% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.00",
          "val2": "8.10",
          "chgp": "319.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-529.00",
          "val2": "-379.50",
          "chgp": "-39.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.00",
          "val2": "8.10",
          "chgp": "-1.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.00",
          "val2": "27.10",
          "chgp": "-70.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-394.00",
          "val2": "-335.30",
          "chgp": "-17.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15,852.90%",
          "val2": "-47,634.90%",
          "chgp": "3,178.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14,596.81% vs -81.71% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 698.35% vs -53.30% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,214.90",
          "val2": "62.70",
          "chgp": "14,596.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,183.20",
          "val2": "-1,243.20",
          "chgp": "677.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "37.70",
          "val2": "40.90",
          "chgp": "-7.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-131.30",
          "val2": "38.60",
          "chgp": "-440.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,455.00",
          "val2": "-1,078.80",
          "chgp": "698.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "776.60%",
          "val2": "-20,243.30%",
          "chgp": "2,101.99%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

34.00

8.10

319.75%

Operating Profit (PBDIT) excl Other Income

-529.00

-379.50

-39.39%

Interest

8.00

8.10

-1.23%

Exceptional Items

8.00

27.10

-70.48%

Consolidate Net Profit

-394.00

-335.30

-17.51%

Operating Profit Margin (Excl OI)

-15,852.90%

-47,634.90%

3,178.20%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 319.75% vs -46.36% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -17.51% vs -46.68% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

9,214.90

62.70

14,596.81%

Operating Profit (PBDIT) excl Other Income

7,183.20

-1,243.20

677.80%

Interest

37.70

40.90

-7.82%

Exceptional Items

-131.30

38.60

-440.16%

Consolidate Net Profit

6,455.00

-1,078.80

698.35%

Operating Profit Margin (Excl OI)

776.60%

-20,243.30%

2,101.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 14,596.81% vs -81.71% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 698.35% vs -53.30% in Dec 2024

All Annual Results